Latest Production News

Mad Paws Holdings Limited reported a milestone positive cash EBITDA of $0.3 million in Q2 FY25, driven by strong marketplace growth and operational efficiencies. The company is amplifying its market presence with a $5.25 million brand campaign in partnership with Seven West Media.

Patrys Limited has halted plans for a Phase 1 trial of PAT-DX1 following disappointing GMP production results, pivoting its development efforts towards PAT-DX3 and exploring new partnerships.

BlueBet Holdings has delivered positive EBITDA for the first half of FY25 ahead of schedule, driven by strategic customer reactivation and enhanced platform efficiencies following its merger with betr.

Sovereign Metals has delivered an Optimised Prefeasibility Study reaffirming Kasiya’s status as a globally significant rutile and graphite project, alongside advancing rehabilitation efforts and positive graphite test results.

SciDev Ltd reports a seasonal revenue dip in Q2 FY25 due to US Oil & Gas sector uncertainty but marks a strategic milestone by securing its first PFAS treatment contracts in Europe.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.

Mad Paws Holdings Limited has reported a strong Q2 FY25 with a 328% increase in cash EBITDA and a 16% rise in marketplace revenue, driven by a strategic above-the-line marketing campaign.

Zip Co Limited has posted record-breaking second quarter results for FY25, driven by exceptional holiday trading and robust growth in the US and ANZ markets. The company reported a 24.8% increase in Total Transaction Volume and a 50.2% rise in cash EBTDA.

Credit Corp Group reported steady H1 FY25 results with operational improvements and confirmed full-year guidance, driven by growth in US debt buying and stable Australian/New Zealand lending.

Credit Corp Group has reported a robust 32% rise in underlying NPAT for H1 FY2025, driven by strong US collections and consumer lending growth, while reaffirming its full-year guidance and announcing a healthy interim dividend.

Top End Energy has taken a major step by acquiring the Kansas Natural Hydrogen Project and advancing its exploration footprint in Australia's Beetaloo Sub-Basin, positioning itself at the forefront of natural hydrogen and unconventional gas development.

LTR Pharma reports compelling clinical results for its nasal spray ED treatment SPONTAN®, demonstrating rapid absorption and strong safety, alongside strategic partnerships and a robust $34 million cash position.